All Activity

I recently considered it could be a thought to create could someone else has been having troubles exploring yet I will be slightly not sure easily feel allowed to set brands and also address about the following. Estudiar Y Aprender

When i got onto your blog site though putting attention simply just a little bit submits. Pleasant strategy for future, I will be bookmarking at a time get ones finish springs up. สมัคร ufa356

Great post! I like how you spotlighted smaller, active communities. those often have the friendliest players and most cooperative environments. It’s cool to see which underrated servers are really thriving.IPTV Sverige

Colorado House lawmakers have approved a Senate-passed bill to allow terminally ill patients to use medical marijuana in healthcare facilities such as hospitals—though advocates have warned that recent amendments to the measure undermine its original intent. Weeks after advancing through the Senate, with amendments, the legislation from Sen. Kyle Mullica (D) cleared the House Health & Human Services Committee in a 10-2 vote on Thursday. It’s now been referred to the House Committee of the Whole before potentially moving to the floor. Reps. Sheila Lieder (D) and Lisa Feret (D) are sponsoring the bill on the House side, and they made the case for the reform before the committee took public testimony on the latest version, which was revised in the Senate to make it so hospitals could voluntarily elect to allow cannabis usage, rather than face a statutory requirement to do so. “This bill was brought to us from a patient perspective,” Lieder said on Thursday. “We want to ensure patients have a continuum of care when they are being treated in a hospital or health care facility.” “There’s been a lot of stakeholdering on this bill in the Senate. Several amendments were passed in the Senate committee without opposition,” she said. “That really brings us to a good place with the hospitals—mainly that participation is not mandated and it’s permissive.” Feret said the legislation “is a really great opportunity for people to have the autonomy to make a decision of how they want to spend their remaining days on this earth and how they want to treat their own pain and giving that autonomy to them.” “Some of the amendments that came through softened it a little bit, and some people are unhappy that it softened,” she said. “But that is the beauty of policymaking a compromise in this building is that we try to get to a good place.” Several advocates testified about those changes, arguing that making it hospitals would have the option—rather than a mandate—to allow medical cannabis use in their facilities would fundamentally undermine the intent of the reform. Jim Bartell, the father of a young California patient who passed and who inspired the policy that’s become known as Ryan’s law in his home state and several others, urged committee members to go back to original language of the bill and “use the original language of ‘shall’ and ‘must'” so that it doesn’t create a patchwork network of health facilities that permit or prohibit medical cannabis use. “For families like mine, this legislation is not theoretical. It’s part of ethical and compassionate care,” he said. Ken Sobel, an attorney with the Cannabis Nurses Network, said the “mandate is critically important because it’s the time that is lost in looking for a facility that allows the use of cannabis that literally compromises the ability to be with your close and loving family member.” “Changing ‘must’ or ‘shall’ to ‘may’ removes that core protection of Ryan’s law,” he said. Lieder, one of the bill sponsors, said in response to the testimony that she had just learned about the amendments that advocates are opposing. So while she moved to report the legislation out favorably, she said she will “gladly continue to work” with colleagues to address the issue. Under SB 26-007, health facilities would be permitted to develop guidelines for the use, storage and administration of medical marijuana. The Colorado Department of Public Health and Environment (CDPHE) would be prohibited from requiring compliance with the policy as a condition of obtaining or renewing a license or certification under the bill. Health facilities would be allowed to suspend the policy change if they risked enforcement action by a federal agency. “In FY 2026-27, workload in the Health Facilities and Emergency Medical Services Division in CDPHE will minimally increase to conduct outreach and education to licensed health care facilities regarding medical marijuana use,” a fiscal impact analysis says. “The department may also require legal services, provided by the Department of Law, related to rulemaking and implementation. This workload can be accomplished within existing appropriations.” Other amendments adopted in the Senate add additional compliance language, clarify that health facilities wouldn’t be required to store or dispense medical cannabis and limit legal liability for health institutions that permit medical marijuana use. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Colorado, the state saw over $1 billion in marijuana sales—a milestone the governor touted in December. Gov. Jared Polis (D) also said last month that his state should not have joined a lawsuit supporting the federal ban on gun ownership by people who use marijuana that recently went before the U.S. Supreme Court—and he personally opposes the state attorney general’s “legal position on this.” Photo courtesy of Max Jackson. The post Colorado Lawmakers Approve Bill To Allow Medical Marijuana Use In Hospitals By Terminally Ill Patients appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Virginia lawmakers have sent the governor legislation to provide a pathway to resentencing for people with prior marijuana convictions. The Senate on Friday voted 21-19 to approve the House of Delegates’s changes to SB 62, sponsored by Senate President Pro Tem Louise Lucas (D). A companion House measure, HB 26 from Rozia A. Henson, Jr. (D), has also advanced this session. Overall, the legislation heading to the desk of Gov. Abigail Spanberger (D) would create a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana could receive an automatic hearing to consider modification of their sentences. The relief would apply to people whose convictions or adjudications are for conduct that occurred prior to July 1, 2021, when a state law legalizing personal possession and home cultivation of marijuana went into effect. Similar legislation was approved by lawmakers last session but it was vetoed by then-Gov. Glenn Youngkin (R). — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Virginia, legislation is also advancing to legalize recreational marijuana sales. Both chambers have approved differing versions of the reform and a conference committee has been appointed to negotiate a single proposal that can be sent to the governor. The post Virginia Legislation To Provide Marijuana Resentencing Relief For Prior Convictions Heads To Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Maryland Senate has passed a bill to protect firefighters and rescue workers from being penalized for using medical marijuana while off duty. About a week after advancing through committee, the legislation from Sen. Carl Jackson (D) advanced on the floor in 33-11 vote on Friday. The Senate last year passed an earlier version that ultimately stalled out in the House. If SB 439 is enacted, state law would be amended to codify that firefighters and other rescue workers who are registered medical cannabis patients could not be penalized over their participation in the state-legal program or for testing positive for marijuana. Employers could not “discipline, discharge, or otherwise discriminate against the fire and rescue public safety employee with respect to the employee’s compensation, terms, conditions, or privileges of employment” based solely on a positive screening for THC metabolites. They also could not “limit, segregate, or classify its employees in any way that would deprive or tend to deprive the fire and rescue public safety employee of employment opportunities or otherwise adversely affect the fire and rescue public safety employee’s status as an employee,” the text of the bill, SB 439, says. However, employers could continue to set zero-tolerance policies for on-duty impairment from cannabis. That issue came up during an initial floor debate on Thursday, where one member pressed the sponsor about enforceability given the lack of technology to detect active impairment from THC. “My concern is, is that I get some guy—I’m having heart issues, and my heart issues go crazier because some dude sits down next to me is like, ‘Yo man, relax. I’m going to take care of you,'” Sen. William Folden (R) said. “I need really sharp responses. I need these people to be very keenly aware. And these people that are doing this have people’s lives in their hands, so that’s where my concern is.” Jackson stressed that, “if there is signs of impairment that is recognized by the employees, then they will be handled appropriately,” pointing out that similar standards apply to other drugs where active impairment can’t be readily tested for, such as opioids. “Our brave fire and rescue personnel risk their lives daily to protect our communities,” Jackson previously told colleagues at a committee hearing last month. “It is imperative that we provide them with the access to the medical care they need, including physician-approved cannabis treatments without fear of employment repercussions.” “Firefighters endure extreme physical and psychological stress due to the nature of their work. Many suffer from chronic pain, post-traumatic stress disorder and other debilitating conditions resulting from the hazards they face in the line of duty. Traditional treatment options such as opioids and other prescription medications can have dangerous side effects, including dependency, cognitive impairment and a reduced ability to function effectively.” “Medical cannabis has been recognized as a safer, viable alternative that would allow firefighters to manage their symptoms while maintaining their ability to perform at the highest level,” he said. The bill’s advancement comes a year after officials in Maryland’s most populous county said they were moving to loosen marijuana policies for would-be police officers in an effort to boost recruitment amid a staffing shortage. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Maryland, lawmakers are also advancing legislation to extend a psychedelics task force through the end of 2027 to develop updated recommendations on expanding therapeutic access to the novel drugs and potentially creating a regulatory framework for broader legalization. Legislators also took up a bill last month to protect the gun rights of medical marijuana patients in the state. Members of the House Judiciary Committee discussed the legislation from Del. Robin Grammer (R), who has sponsored multiple versions of the cannabis and gun rights measure over recent sessions, but they have not yet advanced to enactment. Separately, a Republican congressional lawmaker representing Maryland who has built a reputation as one of the staunchest opponents of marijuana reform on Capitol Hill—and whose record includes ensuring that Washington, D.C. officials are blocked from legalizing recreational cannabis sales—may be at risk of being unseated in November due to redistricting in his state. Photo courtesy of Chris Wallis // Side Pocket Images. The post Maryland Senate Passes Bill To Let Firefighters And Rescue Workers Use Medical Marijuana While Off Duty appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Another Hawaii Senate committee has approved a bill to allow patients to immediately access medical cannabis once their registrations are submitted, instead of having to wait until their cards are delivered as is the case under current law. About a month after clearing a joint House and Senate panel with an amendment, the legislation from Sen. Angus McKelvey (D) moved through the Senate Judiciary Committee on Thursday. The panel also adopted a defective date, March 22, 2075, as a procedural step to flag the bill as needing further discussion before it can be enacted. At its prior committee stop, members adopted a revision to SB 3315, lowering the one-time purchase limit to one ounce of cannabis instead of the two ounces that would have been covered by the measure as introduced. Sen. Joy San Buenaventura (D), chair of the Health and Human Services Committee, said at that panel’s hearing last month that she believes regulators are equipped to track those interim sales “using administrative rules as required,” and she said her support it partly informed by personal experience. The chairwoman said the bill could have helped her family as they supported a terminally ill relative, “where we tried every possible prescriptive ability” and “really needed that one-time use.” San Buenaventura’s committee more recently approved legislation to legalize low-dose and low-potency marijuana, even as members’ counterparts in the House of Representatives have said that cannabis prohibition will not be ended in the state this year. The legislation would allow adults 21 and older to legally possess and use certain amounts of low-dose and low-THC cannabis for personal use, with products limited to a maximum of 5 milligrams of THC per serving. In liquid form, they could have up to 5 milligrams of THC per twelve ounces. The Senate committee action comes after key House lawmakers signaled that cannabis legalization proposals would not be advancing in the 2026 session, citing a lack of sufficient support in their chamber. Despite renewed hopes that those bills—including one from House Judiciary and Hawaiian Affairs Committee Chairman David Tarnas (D) that would have put the issue of legalization before voters at the ballot—would advance this year, the sponsor and House Speaker Nadine Nakamura (D) said there wasn’t enough support within the legislature to pass them this round. State officials in January released a report on the potential economic impact of recreational marijuana legalization in the state, including revenue implications related to domestic and international tourism. All told, researchers said survey data and comparative analyses indicate that Hawaii could see anywhere from $46-$90 million in monthly marijuana sales by year five of implementation, after accounting for a maximum 15 percent tax rate on cannabis products. Hawaii’s Senate last year narrowly defeated a proposal that would have increased fivefold the amount of cannabis that a person could possess without risk of criminal charges. Had the measure become law, it would have increased the amount of cannabis decriminalized in Hawaii from the current 3 grams up to 15 grams. Possession of any amount of marijuana up to that 15-gram limit would have been classified as a civil violation, punishable by a fine of $130. A Senate bill that would have legalized marijuana for adults, meanwhile, ultimately stalled for the session. That measure, SB 1613, failed to make it out of committee by a legislative deadline. While advocates felt there was sufficient support for the legalization proposal in the Senate, it’s widely believed that House lawmakers would have ultimately scuttled the measure, as they did last February with a legalization companion bill, HB 1246. In 2024, a Senate-passed legalization bill also fizzled out in the House. Last year’s House vote to stall the bill came just days after approval from a pair of committees at a joint hearing. Ahead of that hearing, the panels received nearly 300 pages of testimony, including from state agencies, advocacy organizations and members of the public. Gov. Josh Green (D) signed separate legislation last year to allow medical marijuana caregivers to grow marijuana on behalf of up to five patients rather than the current one. And in July, the governor signed another bill that establishes a number of new rules around hemp products in Hawaii, including a requirement that distributors and retailers obtain a registration from the Department of Health. Lawmakers also sent a bill to the governor that would help speed the expungement process for people hoping to clear their records of past marijuana-related offenses—a proposal Green signed into law last April. That measure, HB 132, from Tarnas, is intended to expedite expungements happening through a pilot program signed into law in 2024 by Green. Specifically, it will remove a distinction between marijuana and other Schedule V drugs for the purposes of the expungement program. The bill’s proponents said the current wording of the law forces state officials to comb through thousands of criminal records manually in order to identify which are eligible for expungement under the pilot program. Meanwhile, in November, Hawaii officials finalized rules that will allow medical marijuana dispensaries to sell an expanded assortment of products for patients—including dry herb vaporizers, rolling papers and grinders—while revising the state code to clarify that cannabis oils and concentrates can be marketed for inhalation. The department also affirmed its support for federal marijuana rescheduling—a policy change that President Donald Trump ordered to be completed expeditiously but has yet to come to fruition. Hawaii lawmakers recently advanced a bill to allow qualifying patients to access medical marijuana at health facilities. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Regulators are also launching a series of courses designed to educate physicians and other healthcare professionals about medical marijuana as the state’s cannabis program expands. The underlying medical marijuana expansion bill signed by the governor in late June, in addition to allowing more patients to more easily access cannabis, also contains a provision that advocates find problematic. Before lawmakers sent the legislation to Green, a conference committee revised the plan, inserting a provision to allow DOH to access medical marijuana patient records held by doctors for any reason whatsoever. Photo courtesy of Max Jackson. The post Another Hawaii Committee Approves Bill To Let Patients Access Medical Marijuana Without Waiting For Registration Processing appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Utah lawmakers have sent a bill to the governor that would promote clinical trials into the efficacy of psychedelic-assisted therapy for military veterans with serious mental health conditions. After advancing through the House last month, the Senate passed the legislation from Rep. Jennifer Dailey-Provost (D) and Senate Majority Leader Kirk Cullimore (R) on Wednesday, sending it to Gov. Spencer Cox (R) for final approval. The proposal would authorize the Huntsman Mental Health Institute at the University of Utah to conduct a clinical trial investigating the “safety and feasibility” of psychedelics—including psilocybin, MDMA and DMT—among veterans with treatment-resistant post-traumatic stress disorder (PTSD). The trial would be able to go forward if Huntsman received funding through legislative appropriations and donations that match or exceed the amount required for the study. Results from the trail would need to be reported to the legislature’s Health and Human Services Interim Committee. Participants in the study would need to receive the psychedelic treatment in a controlled clinical setting with a qualified therapist who can deliver “trauma-informed preparatory and integrative psychotherapy to the individual before and after administration of the psychedelic drug,” the text of the bill, HB 390, says. If enacted into law, the study would be expected to begin by January 1, 2027. However, the Huntsman Institute could continue to accept donations after that point if they were unable to reach the funding goal in time. Researchers would have to ensure compliance with both state and federal law, including conducting the trial under a Food and Drug Administration (FDA) investigational new drug application and maintaining Drug Enforcement Administration (DEA) authorization to study Schedule I drugs under federal law. The bill’s advancement comes about two years after the governor allowed a bill to become law without his signature that authorizes a pilot program for hospitals to administer psilocybin and MDMA as an alternative treatment option. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, last year, a federal judge ruled against Utah state and county officials in a lawsuit challenging their prosecution of a Provo City-based religious group that uses the psychedelic fungi as sacrament. That came after U.S. District Judge Jill N. Parrish granted Singularism’s motion for a temporary injunction and ordered police to return psilocybin that was seized last year as part of a raid at its spiritual center. Separately, a Utah lawmaker in January filed a bill for the 2026 session that would decriminalize marijuana and make it so that people caught possessing small amounts of cannabis would not face the threat of jail time for first-time offenses. Utah does have legal medical cannabis under a law the legislature passed in 2018. And that program has significantly grown in the years since, with the state confirming last year that more than 100,000 patients were registered to participate. Photo courtesy of Dick Culbert. The post Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Oregon lawmakers have sent the governor a bill to allow patients with debilitating medical conditions to access medical marijuana in certain health facilities such as hospices. The legislation from Rep. Farrah Chaichi (D) cleared the Senate in a 20-8 vote on Thursday after previously being passed by the House of Representatives in a 39-3 vote earlier last month. It now heads to the desk of Gov. Tina Kotek (D). Chaichi said in testimony to the Senate Health Care Committee last week that the bill is “an important tool to facilitate cannabis use as an alternative or addition to opioid use in end of life care.” “While sometimes necessary, opiates are often overly sedative, preventing quality family interaction in someone’s final days,” she said. “As someone who lost my mother while she was intubated, I know how meaningful it is for patients to be present and in the moments of their last days and weeks with their loved ones. This is a quality of life and a quality of care issue. The bill’s goal is to ensure patients who desire this important and valid medical treatment have access across the board.” HB 4142 would require hospice, palliative and home care organizations, as well as residential facilities, to develop rules permitting registered patients with debilitating conditions to use medical cannabis. The reform is similar to—albeit somewhat more limited than—multiple “Ryan’s law” measures that have advanced in state legislatures across the country. Ryan’s law, which is named after a young cannabis patient in California who passed away, generally refers to a policy broadly permitting medical marijuana use in health facilities such as hospitals. The Oregon bill wouldn’t extend to hospitals, but it would build upon the state’s medical cannabis program in a way that advocates say would meaningfully improve quality of life for seriously ill patients. Under the proposal, the Oregon State Board of Nursing would further be prohibited “from disciplining a nurse who discusses the medical use of marijuana with a patient,” according to a legislative summary. It would additionally make it so eligible health facilities could act as medical marijuana caregivers if authorized by regulators. The legislation “exempts residential facilities that provide a patient with medical marijuana from criminal laws related to the possession, delivery, or manufacture of marijuana” and “allows a conditionally designated residential facility to develop a written policy and train staff before the operative date,” the summary says. If enacted into law, the measure would become operative on January 1, 2027. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Lawmakers in multiple states are advancing similar bills meant to provide patients with access to medical marijuana in health care facilities, with legislators across the U.S. making the case for a policy change they say is necessary to ensure patients have a full range of treatment options at their disposal. The post Oregon Bill To Allow Medical Marijuana In Hospices Heads To Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Multiple veterans groups advised congressional lawmakers about the need to continue exploring psychedelics and marijuana as alternative treatment options for the military veteran population at recent hearings on Capitol Hill. And one veterans advocate cited his experience attending President Donald Trump’s Oval Office signing event for a cannabis rescheduling order as an example of progress in the fight for such alternatives. At a series of joint hearings before the House and Senate Veterans’ Affairs Committees last month and this week, representatives of veterans service organizations (VSOs) testified about the need to promote innovative approaches in mental health treatment, in part to help mitigate the suicide crisis that’s disproportionately impacted those who’ve served. Dan Wiley, national commander of the American Legion, said on Wednesday that the organization’s “number one priority” is “ending veteran suicide,” which involves finding alternatives to conventional therapies because “pills and therapy have objectively not worked.” “We need stronger transition programs, innovative therapies and improved safeguards to medication management,” he said, while going out of his way to add that, after a decade with the American Legion, “I was proud to be in the Oval Office as the president signed an executive order that reclassified cannabis as a Schedule III drug.” “This allows for federal research on how it can reduce drivers of suicide,” he said. “Now the American Legion does not support use of illegal drugs, but we strongly support research that could result in new, effective treatments.” President Donald Trump signed the executive order Wiley referenced in December, directing the attorney general to expeditiously move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). That has yet to happen, however, so cannabis remains strictly prohibited under federal law. “It’s no secret that, for far too long, doctors have prescribed opioids, which are destructive and addictive to our veterans—and the American Legion, by resolution, supports alternative therapies,” Wiley said later in the hearing. He then echoed his prior point about the importance of cannabis rescheduling to that end. The need for alternatives is “one of the reasons why we were proud to be in the Oval Office on December the 18th, when the president signed the executive order reclassifying cannabis from Schedule I to Schedule III,” he said. Also on Wednesday, representatives of the Wounded Warrior Project (WWP) addressed the joint committee, providing members with testimony that emphasized the urgency of expanding research into “innovative and emerging therapies” by investing in “new treatment approaches that provide personalized, effective care for mental health and substance use disorders, including psychedelic-assisted therapy.” A piece of “priority legislation” that could help achieve that goal, WWP said, is the “Innovative Therapies Centers of Excellence Act,” which would providing annual funding to establish psychedelics-focused “centers for excellence” at VA facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine. “Despite significant investments in care, outreach, and awareness across the public, private, and non-profit sectors, ending veteran suicide remains tragically elusive,” the group said. “While risk factors including combat trauma, SUD, and transition stress abound within the veteran community, there are indeed ‘anchors of hope including notable declines in suicide rates among veterans receiving VA health care for anxiety (-40.4 percent), depression (-43.9 percent), PTSD (-34.9 percent), and alcohol use disorder (-16.3 percent).” “With more research and commitment, psychedelic assisted therapy—provided within U.S. borders and through VA—can become the next beacon of light for those hoping to overcome their mental health struggles,” WWP said. “High dropout rates from traditional outpatient mental health care, treatment-resistant diagnoses, and a one-size fits all approach to care are among many factors driving WWP and others to call for accelerated access to evidence-based mental health treatments, expanded psychedelic research, and the elimination of policy barriers that prevent veterans from getting the care they deserve. Direct appropriations to the National Institutes of Health, VA, and DoD for psychedelic assisted therapy addressing difficult-to-treat conditions in veterans and Service members can drive action across the federal system.” The group added that while the most “effective solutions” will involve working with agencies like the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) that are responsible for drug scheduling decisions, “Congress can make a downpayment on progress by passing the Innovative Therapies Centers of Excellence Act.” “This important legislation would require VA to designate at least five ‘innovative therapies centers of excellence’ and direct them to conduct research on the safety and efficacy of innovative therapies including MDMA, psilocybin, ibogaine, and ketamine as treatments for PTSD, anxiety, depression, bipolar disorder, chronic pain, Parkinson’s disease, PTSD, and SUD,” WWP said in testimony for the hearing. “Upon establishing the centers of excellence, VA would then be required to submit a report to Congress on its findings and recommendations to improve the delivery of innovative therapies to veterans. While VA has recently expanded its psychedelic-assisted therapy trials and commitment to additional research, centers of excellence have the potential to confirm the agency’s prioritization of exploring these encouraging new approaches and to create a foundational home for more investment to bring evidence-based, safe, and efficacious treatments to veterans sooner. Success here can also drive further exploration into pilot programs at VA that could, for instance, allow for collaboration with academic medical centers with experience in psychedelic research to operate under modified Food and Drug Administration pathways.” Carol Whitmore, commander-in-chief of Veterans of Foreign Wars (VFW), spoke to the issue in written testimony ahead of a joint committee hearing on Tuesday, referencing federal survey data showing that younger veterans “use marijuana and hallucinogens at significantly higher rates than older veterans, reflecting both changing attitudes toward alternative therapies and persistent gaps in treatment effectiveness for younger service members.” “As a result, some veterans are actively seeking alternative treatment modalities outside traditional VA frameworks,” she said. VFW also specifically noted the potential of MDMA-assisted therapy, which research indicates may be associated with “increased emotional regulation, reduced fear responses, and enhanced processing of traumatic memories.” “Research in these areas is accelerating,” the veterans group said, referencing work that’s underway at the Food and Drug Administration (FDA), National Institutes of Health and U.S. Department of Veterans (VA). “However, VA still lacks sufficient resources, statutory authority, and infrastructure to study these options at scale.” “With nearly 2.5 million veterans seeking mental health care through VA, it is uniquely positioned to lead the nation in developing next-generation PTSD treatments. The VFW urges Congress to pass the Innovative Therapies Centers of Excellence Act of 2025, which would establish five specialized VA medical centers dedicated to evaluating and advancing cutting-edge therapies, including stellate ganglion block, hyperbaric oxygen therapy, ketamine infusion, MDMA-assisted therapy, medical cannabis, and other emerging treatments. Creating these centers of excellence would allow VA to standardize research, accelerate clinical innovation, and expand treatment options for veterans who have not found relief through traditional therapies.” Sen. Dan Sullivan (R-AK) emphasized his own interest in promoting alternative therapies, and VFW’s Whitmore told the senator at the hearing that veterans “should not have to start over,” and there are “so many different modalities that the VFW would like Congress to look at [such as] hyperbaric treatment and medical cannabis.” “There are many different things that can be done. A veteran doesn’t want another pill thrown at them,” she said. Iraq and Afghanistan Veterans of America (IAVA) also provided written testimony for Tuesday’s hearing, briefly noting that “interest in understanding alternative therapies, such as psychedelics, to address underlying drivers of suicidality has become increasingly popular in policy and veteran circles, yet more research is needed to fully understand their effectiveness.” Last week, Disabled American Veterans’s (DAV) Coleman Nee urged committee members in written testimony to prioritize the “unique needs of the veteran population,” which includes recognizing the “importance of alternative and emerging therapies, such as psychedelics, which have shown promise in being more effective than traditional methods.” “By exploring and implementing these innovative treatments, we can better support the mental health and well-being of veterans,” he said. Rep. Nancy Mace (R-SC), a proponent of psychedelics and cannabis reform, specifically asked about alternative therapies at an in-person hearing late last month, and Nee told the lawmaker that he’s personally a “huge believer” in the potential of novel treatment options. “I’ve used alternative and naturalistic therapies for my own disabilities. We’ve done a significant amount of work on that and, in fact, we’ve done a significant amount of research,” he said, turning to DAV’s Jon Retzer for additional input. “We really appreciate alternative options [and] research on psychedelics,” Retzer said. The VSO testimony comes as U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. reiterates his own interest in expanding psychedelics access, telling Joe Rogan on a recent podcast episode that the Trump administration is “very anxious” to create a pathway for the novel therapies and that top officials across federal agencies want to “get it out to the public as quickly as possible.” Meanwhile, in November, Kennedy, Vice President JD Vance, the FDA commissioner and other Trump administration officials attended a “Make America Healthy Again” summit that featured a session dedicated to exploring psychedelic medicine. In June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” The secretary also said in April that he had a “wonderful experience” with LSD at 15 years old, which he took because he thought he’d be able to see dinosaurs, as portrayed in a comic book he was a fan of. Last October, Kennedy specifically criticized FDA under the prior administration over the agency’s “suppression of psychedelics” and a laundry list of other issues that he said amounted to a “war on public health” that would end under the Trump administration. Photo elements courtesy of carlosemmaskype and Apollo. The post Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To Mitigate Suicide Crisis appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

We offer the best call girl services with a choice of beautiful, sexy, and stunning escorts at low rates near hotels or private rooms. https://andheri.chdagency.in/ https://bangalore.chdagency.in/ https://bhopal.chdagency.in/ https://bhubaneswar.chdagency.in/ https://chennai.chdagency.in/ https://dehradun.chdagency.in/ https://delhi.chdagency.in/ https://dwarka.chdagency.in/ https://faridabad.chdagency.in/ https://ghaziabad.chdagency.in/ https://goa.chdagency.in/

Farm Bill advances with hemp provisions; NH legalization rejected; AZ cannabis smoke bill amended; OK gov on medical marijuana; New cannabis coalition Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Department of Transportation sent a reminder warning substance abuse professionals to disregard attempts to justify positive drug tests for THC due to workers’ use of medical marijuana or hemp oil. The House Agriculture Committee approved a Farm Bill that includes certain provisions to aid the hemp industry—but without voting on amendments that sought to delay the federal recriminalization of hemp THC products. Oklahoma Gov. Kevin Stitt (R) said the state’s medical cannabis program “has failed” and “it’s time to shut this broken system down and protect our kids and communities.” “We don’t need more weed shops than pharmacies.” The New Hampshire Senate rejected a marijuana legalization bill that had been passed by the House of Representatives. The Arizona Senate scaled back legislation to punish people for creating “excessive” marijuana smoke or odor by removing most criminal penalties. National Compassionate Care Council founding member Sasha Kalcheff-Korn explains in a Marijuana Moment op-ed how the new group will unite the healthcare-aligned sector of the cannabis industry “around a single mission: turning executive momentum into durable policy that actually reaches people” as rescheduling proceeds. “This is not about advancing an industry for its own sake. It is about ensuring that when patients and healthcare providers discuss cannabinoid therapy, they can do so within a clear, evidence-informed federal framework.” A New Jersey appeals court ruled that municipalities cannot deny requests for local support to open marijuana dispensaries without explaining those decisions. / FEDERAL The Department of Justice is prosecuting a Kansas hemp retail store owner for alleged marijuana and weapons violations. Defense Secretary Pete Hegseth is urging Latin American countries to take a more aggressive approach against drug cartels. The National Advisory Council on Drug Abuse will meet on Monday. / STATES Connecticut’s attorney general discussed efforts to combat unlicensed marijuana sales. The West Virginia House of Delegates passed legislation to allow medical cannabis edibles and to reallocate medical marijuana revenue. The Mississippi Senate Public Health and Welfare Committee rejected a House-passed bill to allow medical cannabis use in healthcare facilities. A Louisiana representative spoke about her bill to create a marijuana legalization pilot program. Pennsylvania lawmakers discussed the prospects of legalizing marijuana. Ohio regulators announced a recall of marijuana products that are not marked with a universal THC symbol on each serving. Alabama’s top medical cannabis regulator said sales to patients should begin in late April or early May. Washington State regulators sent guidance on cannabis tax payment processes. Michigan regulators published a cannabis business compliance best practices guide. California officials published a report on the first five years of the Cannabis Watershed Protection Program. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL New York City’s mayor visited a safe consumption site for illegal drugs. / INTERNATIONAL New South Wales, Australia’s premier said his government will support legislation to protect medical cannabis patients from DUI charges. / SCIENCE & HEALTH A study found that “patients positively endorsed cannabis use during cancer care.” A study found that “approximately one-third of patients reported cannabis use during [substance use disorder] treatment” and that “motivations for cannabis use were to alleviate pain, pain-related anxiety and poor sleep quality, and viewing cannabis as a harm reducing therapeutic.” / ADVOCACY, OPINION & ANALYSIS A poll of South Carolina voters found that they support regulating instead of banning hemp products, 73 percent to 13 percent. / BUSINESS Cresco Labs Inc. reported quarterly net revenue of $161.5 million and a net loss of $88.9 million. Splash Beverage Group, Inc. executed a non-binding letter of intent for a proposed merger with Medterra CBD, LLC. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Feds warn about medical cannabis & hemp in drug tests (Newsletter: March 6, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

cookie clicker is a primal satisfaction in watching your "Cookies per Second" (CpS) jump from 10 to 10 quadrillion.

The New Hampshire Senate has defeated a House-passed bill to legalize marijuana in the state—the latest blow for advocates in a years-long fight to end prohibition in the Granite State. Weeks after members of the Senate Judiciary Committee rejected the legislation from Rep. Jared Sullivan (D), deeming it inexpedient to legislate, the full chamber killed the proposal by approving a motion to table it in a 15-9 vote on Thursday. The bill cleared the House earlier this year on a 208-135 vote. “Granite Staters overwhelmingly want cannabis legalized,” Sen. Donovan Fenton (D) said ahead of the Senate vote. “This bill would provide roughly $60 million in revenue over three years, money that could help lower costs for New Hampshire residents and provide housing and strengthen services.” If enacted, HB 186 would have legalized possession of up to 2 ounces of cannabis flower, 10 grams of concentrates and products with up to 2 grams of THC for adults over 21 years of age. They could also have grown six plants at home, three of which could have been mature. Past cannabis possession convictions would have been vacated, and non-discrimination protections for consumers would have been established, including for access to medical care, public benefits, child custody and government employment. A new Cannabis Commission would have been established to license and regulate the marijuana industry, along with a Cannabis Advisory Board. Recreational cannabis sales would have been taxed at 8.5 percent, with revenue split between program administration, municipalities, substance misuse programs, public safety agencies and the state general fund. Localities across the state would have had ballot referendums asking voters if they wanted to opt in to allowing retail marijuana sales. Sullivan’s legalization bill is one of several cannabis proposals filed for the 2026 session, including legislation from Rep. Jonah Wheeler (D) that seeks to put a constitutional amendment on the state ballot that would let voters decide if they want to legalize marijuana for adults 21 and older, allowing them to “possess a modest amount of cannabis for their personal use.” Members of the House Criminal Justice and Public Safety Committee took up that legislation in January. Gov. Kelly Ayotte (R) has already threatened to veto any legalization bill that reaches her desk, though the constitutional amendment proposal would not require gubernatorial action. The governor said in August that her position on the reform would not change even if the federal government moved forward with rescheduling the plant. Since then, President Donald Trump has directed the attorney general to finalize the process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). At a committee meeting last year, Sullivan ultimately made a persuasive argument for advancing his legalization bill, pointing out that the House has repeatedly passed similar legislation and that the chamber should stand its ground, forcing the Senate and governor to again go on record with their opposition to a policy popular among voters. “We know where it’s going to go. Let’s send a virtue signal,” Sullivan said. “Let them be the ones that are pissing off voters who care about this.” In the Senate, the Judiciary Committee in January also took up a bill from Sen. Donovan Fenton (D) that would allow adults over the age of 21 to legally possess up to four ounces of cannabis in plant form and 20 grams of concentrated cannabis products, as well as other products containing no more than 2,000 milligrams of THC. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the New Hampshire House last month approved a bipartisan bill to legalize the regulated use of psilocybin for medical purposes. Last June, the New Hampshire Senate voted to scrap compromise legislation that would have lowered the state’s criminal penalty for first-time psilocybin possession while also creating mandatory minimum sentences around fentanyl. As originally introduced, the legislation would have completely removed penalties around obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on a noncommercial basis. However a House committee amended the bill before unanimously advancing it last March. Photo courtesy of Philip Steffan. The post New Hampshire Senate Kills House-Passed Marijuana Legalization Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Arizona senators have dialed back a pair of measures that would penalize people who create “excessive” amounts of marijuana smoke or odor, with members advancing revised versions of the legislation following criticism that, as introduced, they would have added criminalization provisions back into the state’s cannabis use laws. The latest bill and companion resolution, sponsored by Sen. J.D. Mesnard (R), were amended by the Senate Committee of the Whole on Wednesday, with a floor vote on third reading now imminent. While the bill would on its own enact a statutory policy change, the separate resolution would put the issue before voters to decide. As the original proposals moved through the legislative process, advocates and certain lawmakers voiced concerns about undermining the will of voters who passed legalization at the ballot, as well as the ambiguity around enforceability and what constitutes “excessive” marijuana smoke. The legislation was previously amended in committee last month in an attempt to provide a clearer definition of “excessive” smoke and remove a reference to making the offense a “crime.” The latest revised definition of excessive cannabis smoke or odor describes it as “airborne emissions resulting from the burning, heating or vaporizing of marijuana or marijuana products,” according to a summary of the adopted floor amendment. Such emissions must also be “detectable by a reasonable person of ordinary sensibilities on other private property” and “occur for more than 30 consecutive minutes on a single occasion or on three or more separate days within a 30-day period.” Members further revised the legislation in response to criticism that the committee-passed versions continued to lack clarity and would pose the threat of criminalization by making the offense a class 3 misdemeanor, punishable by up to 30 days in jail, a maximum $500 fine and up to one year of probation. That, too, was ultimately changed in the bill (SB 1725) and resolution (SCR 1048) that are teed up to advance through the full Senate. Specifically, the legislation stipulates that “excessive marijuana smoke or odor is a public nuisance if the person’s conduct is intentional or the person knowingly and substantially interferes with the comfortable enjoyment of life or property,” a summary of the amendment says. The proposals also now specify that “lawful possession or use of marijuana does not preclude a finding of nuisance, except that a court may consider possession of a valid registry identification card as a mitigating factor,” and they provide that “a person is not liable for committing a private nuisance unless the person has received notice of the interference and fails to abate it within five days.” Under the revised legislation, the affected party would first have to file a compliant with local officials before they pursue action with the state, but only if the municipality has already adopted an ordinance regulating excessive cannabis smoke or odor. A person would be deemed in violation of the law if a local court has issued a written order directing them to “abate excessive marijuana smoke or odor that constitutes a nuance” and that person “knowingly violates or refuses to comply with the order.” Each day of non-compliance after failing to adhere to the order would be consider a separate offense, and failure to comply would be a petty offense, rather than a criminal violation. “Based on feedback from folks who agree with the premise of the bill but wanted a different approach, this moves the bulk of it into civil statute—makes this a petty offense,” Mesnard said. “It also establishes greater clarity on what we’re talking about.” “So as far as excess marijuana smoke or odor, we’ll be talking about something that’s a lengthy period of time or occurring with greater frequency,” he said. “It walks through the process that you should be reaching out to your local government as a first step, if they have anything on the books regarding this issue, and the only thing left in place on the criminal side is if something is substantial and deliberate that’s occurring.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background of this legislation, anti-cannabis activists are working to put an initiative on the state’s November ballot that would significantly roll back its voter-approved marijuana legalization law. A GOP congressional lawmaker said recently he’d like to see his state take that action—but he also acknowledged that President Donald Trump’s recent federal rescheduling order could complicate that prohibitionist push. Under the proposal, possession would remain lawful if voters chose to enact the initiative—and Arizona’s medical marijuana program would remain intact—but the commercial market for recreational cannabis that’s evolved since voters approved an adult-use legalization measure in 2020 would be quashed. A findings section on the latest initiative states that “the proliferation of marijuana establishments and recreational marijuana sales in this state have produced unintended consequences and negative effects relating to the public health, safety, and welfare of Arizonans, including increased marijuana use among children, environmental concerns, increased demands for water resources, public nuisances, market instability, and illicit market activities.” “Arizona’s legal marijuana sales have declined for two consecutive years, resulting in less tax revenue for this state, while some patients have relied on recreational use of marijuana instead of utilizing the benefits of this state’s medical marijuana program,” it says. The initiative would also instruct the legislature to make conforming changes by amending existing statute as it relates to the commercial industry, including tax and advertising rules. In order to make the ballot, the campaign will need to collect 255,949 valid signatures by July 2. If the proposal goes to voters and is approved, it would take effect in January 2028. It remains to be seen if there will be an appetite for repeal among voters, as 60 percent of the electorate approved legalization at the ballot in 2020. What’s more a poll from last year found majority support for medical cannabis legalization (86 percent), adult-use legalization (69 percent) and banking reform (78 percent). Meanwhile, senior residents in Arizona independent living communities could soon see a different kind of care service available in their neighborhoods: Kiosks allowing them to view and buy marijuana products from licensed dispensaries. The retailer Life Is Chill and cannabis technology company LoveBud announced last week that they were partnering for the launch of the novel initiative, which will involve deploying the kiosks in participating senior living communities that residents can use to learn about and order marijuana products for delivery. Photo courtesy of Martin Alonso. The post Arizona Senators Scale Back Bills To Punish Marijuana Users Over Excess Smoke Or Odor Complaints appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Federal policy must reflect evidence and science, not dispelled myths and tired stereotypes.” By Sasha Kalcheff-Korn, National Compassionate Care Council Recent federal action initiating a review of cannabis scheduling and signaling interest in expanding cannabinoid research reflects a growing willingness to examine how federal policy aligns with emerging evidence and real-world patient experience—but it also highlights a significant research gap that must still be addressed. If approached thoughtfully, this moment represents a rare opportunity to bring scientific rigor, clearer regulatory standards and responsible oversight to a space that has operated within a fragmented, state-by-state system for decades. The new National Compassionate Care Council, announced this week, was formed to help meet that moment. We represent the healthcare-aligned sector of the cannabis industry—from physicians to patients to responsible manufacturers—united around a single mission: turning executive momentum into durable policy that actually reaches people. This is not about advancing an industry for its own sake. It is about ensuring that when patients and healthcare providers discuss cannabinoid therapy, they can do so within a clear, evidence-informed federal framework. Opportunities like this do not move forward automatically. Opponents are already lining up to impede this progress. Rep. Andy Harris (R-MD) declared openly that he hopes the Department of Justice takes two decades to complete rescheduling. At least that position is clear. More concerning are the quieter efforts, procedural delays, bureaucratic slow-walking and political hesitation that can stall reform without ever openly debating its merits. The strategy is the same as it has always been: run out the clock on patients who do not have time to wait. The administration is right that federal policy has suppressed research for too long. But let’s be clear about what that suppression actually means: it means the “lack of evidence” cited by opponents was manufactured by the same regulatory barriers they defend. It is the absence of federally sanctioned research infrastructure, not the absence of therapeutic potential. And the research that has been done has borne that to be true. One of the largest-ever reviews of cancer and cannabis found a 75 percent positive consensus supporting cannabis’s potential benefits for cancer symptoms and tumor-related outcomes. A survey of veterans who used medicinal cannabis found that 91 percent said that medicinal cannabis treatment led to a greater quality of life, and 21 percent additionally reported that their medicinal cannabis use reduced the use of opioids. Another large-scale clinical trial found that patients using a full-spectrum cannabis oil saw a 30 percent reduction in back pain after 12 weeks. The Food and Drug Administration’s own review that produced its Schedule III recommendation saw this reality and acknowledged that medicinal cannabis has demonstrated meaningful relief for patients with chronic pain and other conditions. That conclusion didn’t emerge from a vacuum. It reflects decades of real-world patient experience, observational data collection, and medicinal use that persisted despite federal barriers to research. President Donald Trump’s rescheduling executive order calls for the integration of real-world evidence to inform federal standards of care. That is both appropriate and highly necessary given the stakes. Our members are investing in ethically rigorous and peer-reviewed research, standardized dosing frameworks and compliance infrastructure that can meet that directive. We are not asking policymakers to rely solely on anecdotes. That would just gift our detractors the opening they are looking for. We are actively building the evidence base that patients and providers deserve. Because that is what the moment requires. If this program is allowed to succeed on its merits, it will confirm what millions of Americans already know and create a federal framework that protects patients, holds manufacturers accountable and gives healthcare providers the data they need to make informed recommendations. If it is delayed indefinitely, uncertainty will continue and it will be patients who bear the consequences. For families navigating chronic illness today, this is not an abstract debate. It is the lived reality of not being able to achieve the quality of life that patients deserve when it is abundantly available. Federal policy must reflect evidence and science, not dispelled myths and tired stereotypes. Generational reform has always attracted generational resistance. We are prepared for that fight. But we are not willing to wait decades to have it. For the patients counting on this, the answer cannot be someday. It has to be now. Sasha Kalcheff-Korn is a founding member of the National Compassionate Care Council and executive director of Realm of Caring, a Colorado-based nonprofit that advocates for and connects people to cannabinoid therapy. The post New Cannabis Group Will Help Ground Policy In Science And Patient Experience As Trump’s Rescheduling Move Advances (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Republican governor of Oklahoma says the state’s medical marijuana program has “failed,” and it’s “time to shut this broken system down” amid reports about youth cannabis use. Gov. Kevin Stitt (R) said on Tuesday that the voter-approved “experiment” with medical marijuana legalization has led him to conclude that the program hasn’t worked, citing a recent report released by the TEXOMA High Intensity Drug Trafficking Area (HIDTA), which was tasked by the legislature to assess the impact of the state’s cannabis laws. “Youth use of marijuana is up. ER visits are up. Cartel crime is up. Massive amounts of oversupply are flooding the black market,” the governor said. “We don’t need more weed shops than pharmacies.” “It’s time to shut this broken system down and protect our kids and communities,” he said, sharing a link to a News 9 report about HIDTA’s recent findings. Oklahoma’s marijuana “experiment” has failed. Youth use of marijuana is up. ER visits are up. Cartel crime is up. Massive amounts of oversupply are flooding the black market. We don’t need more weed shops than pharmacies. It’s time to shut this broken system down and protect… — Governor Kevin Stitt (@GovStitt) March 3, 2026 “As indicated through the data, marijuana legalization in Oklahoma has had a significant impact on the state, with increased marijuana use among both youth and adults,” HIDTA claimed. “Along with a rise in marijuana related health issues such as emergency department visits, hospitalizations, and calls to the poison control center.” How the governor envisions shuttering the program is unclear, but Stitt is echoing points he made prior to the release of the latest report. He said during a State of the State address last month that he wants voters who approved medical marijuana legalization at the ballot to revisit the reform. That’s drawn mixed reactions from lawmakers, including those within the governor’s own party. Senate President Pro Tempore Lonnie Paxton (R), for example, initially expressed openness to the idea—but he ultimately determined it’d be “really hard to completely undo” legalization and unfair to licensed medical cannabis operators who “invested their life savings into this program” and are “trying to do this for the Oklahomans that need that product—not for recreational, but for actual medicinal purposes.” “It’s hard to unring that bell,” he said. “What I’m going to suggest to the governor is that we don’t run a state question on that, but instead we continue to push the regulations [and] we continue to regulate the industry.” House Speaker Kyle Hilbert (R) has also largely dismissed the prospect of upending the state’s medical cannabis program. He said Oklahomans have already drawn a clear distinction: They support medical marijuana and “resoundingly” oppose adult-use legalization, based on past election results. Oklahoma Attorney General Gentner Drummond (R) was asked last month about the governor’s call to have voters revisit the state’s medical marijuana program, and he said he’d “love” to see the state’s medical marijuana program wiped out. However, he cautioned that doing so would mean reimbursing the hundreds of licensees participating in the market because the state would be “taking” a revenue source away from them. Meanwhile, Senate Minority Leader Julia Kirt (D) said she’s “not into revisiting state questions,” and lawmakers should “trust the people, and we should actually implement them as well.” “This legislature, before our time, could have made a decision to put guardrails in place before this state question passed,” the senator said. “Instead, they stuck their head in the sand and let that question pass and be mayhem.” Chris Anoatubby, the lieutenant governor of the Chickasaw Nation in Oklahoma, aligned himself with Stitt’s position, stating that the medical marijuana program as currently implemented has “been a problem all over Oklahoma.” He added that he’d “absolutely” support “reforming” the cannabis law. During his speech last month, the governor complained that the state has “more dispensaries than we do pharmacies,” adding that marijuana retailers “hide an industry that enables cartel activity, human trafficking, and foreign influence in our state.” While regulators and law enforcement have “done incredible work to hold back the tide of illegal activity,” Stitt said, the industry is “plagued by foreign criminal interests and bad actors, making it nearly impossible to rein in.” “We can’t put a band-aid on a broken bone,” he said. “Knowing what we know, it’s time to let Oklahomans bring safety and sanity back to their neighborhoods. Send the marijuana issue back to the vote of the people and shut it down.” While the governor’s rhetoric signals he may be interested in seeing the medical cannabis industry shuttered altogether, it’s not clear what exactly he wants voters to decide on and his office has not released specific language of a proposed ballot measure. Back in 2022, Stitt similarly used his State of the State address as an opportunity to dig at the voter-approved medical marijuana law, arguing that residents were misled by proponents of the ballot initiative. Meanwhile, in November, Oklahoma activists withdrew an adult-use marijuana legalization initiative that they’d hoped to place on the state’s 2026 ballot. After a short but aggressive signature push to secure ballot placement, Oklahomans for Responsible Cannabis Action (ORCA) ultimately did not turn in its petitions by the deadline, according to the secretary of state’s office. ORCA said following the governor’s speech that the call for an end to the medical cannabis program is “simply an admission of his administration’s failure.” “While we were busy advocating for common sense regulation, his appointees were busy importing thousands of illegal [Chinese Communist Party] grows,” the group said.”Fortunately, the Feds picked up prosecution.. because they weren’t getting held accountable by the State.” “Fortunately, [Stitt] has no power here. It will take a vote of both the House and Senate to propose a vote to cancel SQ 788,” they said.”As we all move forward we must continue to be forward thinking, not backward acting. We look forward to talking and working with lawmakers, now and in the future.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, law enforcement leaders with the Oklahoma Association of Chiefs and Oklahoma Bureau of Narcotics and Dangerous Drugs have been raising concerns about cannabis. Also in Oklahoma, lawmakers last March advanced a bill aimed at protecting gun rights of state-registered medical marijuana patients, although federal law still bars cannabis users from owning firearms regardless of their patient status. Another state bill filed last year by a GOP legislator would criminalize the use of medical cannabis during pregnancy. Photo courtesy of Chris Wallis // Side Pocket Images. The post Oklahoma Governor Says Medical Marijuana Law Has ‘Failed’ And State Should ‘Shut This Broken System Down’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“While the City Council was permitted to consider all relevant evidence and has wide discretion…we hold that the City Council has to provide a discernible reason for its determination.” By Sophie Nieto-Muñoz, New Jersey Monitor New Jersey’s cannabis industry scored a victory Tuesday when a state appellate panel ruled that municipalities must explain why they deny requests for local support to open dispensaries, a decision that could have implications for legal weed retailers statewide. The 23-page decision rejects an argument by the Burlington City Council that it is allowed to reject those requests without explaining why. The council was sued by the owners of a planned cannabis dispensary after council members denied the owners’ request for a resolution of local support, a document required to open recreational cannabis dispensaries in New Jersey. “While the City Council was permitted to consider all relevant evidence and has wide discretion under its general police powers to deny the issuance of an ROS, we hold that the City Council has to provide a discernible reason for its determination,” reads the ruling by Judge Lisa Perez Friscia. Tuesday’s decision rejects a lower court judge’s ruling that required Burlington to issue the resolution of support to the owners of the planned dispensary, called Higher Breed. The newer ruling requires the Burlington council to reconsider Higher Breed’s request for support and then issue a resolution that provides a basis for the council’s decision. A request for comment from Higher Breed’s attorneys was not returned. New Jersey voters opted in 2020 to legalize cannabis, but the state’s legalization law allowed towns to opt out of cannabis sales, and about 70 percent of towns did so. The Cannabis Regulatory Commission, which is tasked with approving cannabis retail licenses, requires prospective license holders to obtain a resolution of local support from the town where they plan to operate. In December 2023, Higher Breed, owned by Jim and Karen Waltz, applied to the Burlington City Council for a resolution of local support for a store on East Route 130. After hearing from a real estate broker who does not live in Burlington and claimed the property’s owner was “dishonest” and owed him a real estate commission, the council ultimately rejected Higher Breed’s request for a resolution of local support. Higher Breed then sued. Tuesday’s decision agrees that Burlington’s council has the authority to reject a request for a resolution of local support for a cannabis retailer, but the judges said the council cannot do so without providing a reason. State law “offers no exemption for municipalities from providing in an adopted resolution the basis for denying local support,” the decision reads. This story was first published by New Jersey Monitor. Photo elements courtesy of rawpixel and Philip Steffan. The post New Jersey Cities Must Explain Marijuana Business Denials, Court Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Members of a key congressional committee have advanced a large-scale agriculture bill that hemp industry stakeholders hoped could be used to delay a pending federal ban on cannabinoid products containing THC. But while the latest Farm Bill does contain certain hemp provisions, it seems unlikely at this stage that the measure will be used to prevent that market upheaval. The House Agriculture Committee on Tuesday and Wednesday held a markup of the 2026 Farm Bill, ultimately approving it by a vote of 34-17. Despite a push from lawmakers and hemp interests, however, two GOP-led amendments seeking to push back the THC recriminalization timeline were not approved after the chairman determined they were not germane to the underlying legislation. Rep. Jim Baird (R-IN) filed the amendments ahead of the markup, with one proposal to delay the hemp ban that’s currently set to take effect in November by one year and another that would give the industry two additional years as they work to put forward a regulatory alternative for intoxicating cannabinoid products. Baird has separately introduced standalone legislation that would push the implementation back by two years. Baird is not present on Capitol Hill this week due to the recent death of his wife, so Rep. Angie Craig (D-MN), the panel’s minority ranking member, presented the two-year-delay amendment on his behalf—though after a brief discussion she withdrew it without forcing a vote on the issue. “This amendment seeks to delay the last-minute changing of definitions around him that was inserted into a recent appropriations bill, which has caused market uncertainty and widespread economic anxiety among farmers, processors, retailers and consumers back home in Minnesota and of course, in [Baird’s] home state as well,” she said. The way Congress’s GOP majority included hemp THC recriminalization provisions in a spending bill last year was “just plain wrong,” Craig said. “Literally planning decisions are being made right now by hemp farmers. That’s why I called for a comprehensive regulatory framework for the safe production and marketing of hemp the right products, a framework that puts in place clear rules of the road for growers and retailers, includes protections for children and safeguards for consumers, and brings the relevant federal agencies, whether it’s [the Food and Drug Administration], [The U.S. Department of Agriculture] or other related agencies, into the process at the appropriate point for the appropriate product.” “I stand ready to work with my colleagues, both in this committee and in other committees on both sides of the aisle to come together and move forward, not backward on this issue. This is an industry with tremendous room for innovation and growth… This is an industry that we shouldn’t be demonizing and fearing, but it should be brought into the light and smartly regulated to protect the safety and wellbeing of our communities, while giving entrepreneurs, farmers, small businesses opportunities to develop new markets, create new products and meet the needs of consumers. By the way, more than a few Minnesotans have reached out to me about this issue, concerned that big whiskey distillers in Kentucky are trying to restrict consumer choice in Minnesota. That doesn’t sit well with me at all, and it certainly doesn’t sit well with my hockey moms. I think our nation would be better for having a comprehensive regulatory framework in this space, and we in Congress need to come together to figure this out.” Rep. Glenn “GT” Thompson (R-PA), chair of the Agriculture Committee, had reportedly determined in advance of this week’s meetings that Baird’s hemp amendments were not germane to the bill. “The [agriculture] appropriations bill that passed last fall brought clarity to the industry on what is or is not allowable under the definitions of hemp,” he said Wednesday. “Importantly, to many in this room today, that language addressed the issue of final form products that have been the source of many public health concerns since the 2018 Farm Bill because they lacked a federal regulatory structure.” “A comprehensive regulatory framework for these products falls outside the jurisdiction of this committee, and instead of falls within the jurisdiction of our colleagues…on Energy and Commerce,” the chairman said. While the House committee didn’t vote on the hemp THC ban delay amendments, the base bill that was marked up does include several sections that concern cannabis grown by farmers for industrial purposes such as fiber and grain. For example, the legislation would amend existing statute related to the development of industrial hemp production regulatory plans by states and tribes—including surrounding polices for testing, sampling, background checks and record-keeping. “Within this base bill, we do support our hemp farmers in a couple of different ways,” Thompson said at the markup. “We direct USDA to expand and access more laboratories for our hemp farmers to be able to have their commodity tested… Also, we have provided states more flexibility in this space.” Here’s a summary of the hemp language in the 2026 Farm Bill from House Agriculture Committee staff: “Sec. 10005. Hemp production. Section 10006 amends subtitle G of the Agricultural Marketing Act of 1946. Subsection (a) amends section 297B to require State and Tribal plans to include a procedure under which a hemp producer shall be required to designate the type of production of the hemp producer; allow State and Tribal plans to include a procedure for the use of visual inspections, performance-based sampling methodologies, certified seed, or a similar procedure when developing sampling plans for industrial hemp; allow State and Tribal plans to include a procedure for eliminating the 10-year period of ineligibility following the date of conviction for producers of industrial hemp with a felony related to a controlled substance; require documentation during inspections that demonstrates a clear intent to produce industrial hemp for producers under a State or Tribal plan that includes procedures for reducing or eliminating sampling or testing requirements for industrial hemp; allow testing if a producer of industrial hemp fails to provide required documentation; require the State or Tribe to report a producer of industrial to the Attorney General and applicable law enforcement officers if that producer violated the State or Tribal plan by producing a crop that is inconsistent with the designation of industrial hemp; and ban any person who knowingly produced a crop that is inconsistent with the designation of industrial hemp from obtaining a hemp license for 5 years. Subsection (b) amends section 297C to require a Department of Agriculture plan to include a procedure under which a hemp producer shall be required to designate the type of production of the hemp producer; allow a Department of Agriculture plan to include a procedure for the use of visual inspections, performance-based sampling methodologies, certified seed, or a similar procedure when developing sampling plans for industrial hemp; allow a Department of Agriculture plan to include a procedure for eliminating the 10-year period of ineligibility following the date of conviction for producers of industrial hemp with a felony related to a controlled substance; require documentation during inspections that demonstrates a clear intent to produce industrial hemp for producers under a Department of Agriculture plan that includes procedures for reducing or eliminating sampling or testing requirements for industrial hemp; allow testing if a producer of industrial hemp fails to provide required documentation; and requires the Secretary to collect information related to the designation of the type of production of hemp producers and the laboratory certificate of analysis for hemp disposed of. Subsection (c) amends section 297D to require the Secretary of Agriculture to establish a process by which the Department of Agriculture can issue certificates of accreditation to laboratories for the purposes of testing hemp.” Meanwhile, Wisconsin’s governor is among the most recent voices to call on congressional lawmakers to urgently take action to block the federal hemp THC ban, which threatens to wipe out much of the state’s cannabis market. It’s an issue he said is “intensified” by the fact that the state has yet to legalize marijuana for medical or adult use. On the other side of the debate, a coalition of law enforcement and anti-drug groups recently implored congressional leaders to oppose efforts to delay the implementation of the hemp THC ban. Hemp and alcohol industry stakeholders are on full alert amid a pending ban on hemp THC products—including increasingly popular cannabinoid beverages—and a former Democratic congressman who owns a major alcohol company recently spoke at Wine & Spirits Wholesalers of America’s (WSWA) Access LIVE 2026 event in Las Vegas where he and others discussed the policy landscape around hemp and how to avert an industry-wide upheaval. WSWA, which hosted the event, has been closely monitoring federal hemp policy developments, and the association was among the first in the sector to call on Congress to dial back language in the now-enacted law set to ban most consumable hemp products, while proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Other major alcohol retailers came together in January to encourage Congress to delay the enactment of the law Trump signed that will federally recriminalize hemp-derived THC beverages and other products. Lawmakers from across the aisle have been raising concerns about the potential consequences of the hemp redefinition, which would eradicate most consumable cannabinoid products that have become commonplace in states across the U.S., including those where marijuana hasn’t been legalized. Rep. James Comer (R-KY) and Kentucky Agriculture Commissioner Jonathan Shell are among the critics of the ban, and they sent a letter to Sen. Mitch McConnell (R-KY) last month imploring him to use his influence to avert the recriminalization, at least on a temporary basis, by supporting the proposed implementation delay. While McConnell championed hemp legalization under the 2018 Farm Bill, however, the former Senate majority leader has supported unraveling the hemp THC market that he’s described as an unintended consequences of the broader agriculture legislation. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis. The provisions set to take effect later this year specify that, within one year of enactment, the weight will apply to total THC—including delta-8 and other isomers. It will also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).” The new definition of legal hemp will additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it. Legal hemp products will be limited to a total of 0.4 milligrams per container of total THC or any other cannabinoids with similar effects. Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies were supposed to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other known cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.” However, FDA appears to have missed that deadline. A spokesperson told Marijuana Moment last month that the lists would be posted in the Federal Register when they’re available. Photo courtesy of Brendan Cleak. The post Congressional Lawmakers Approve Farm Bill With Hemp Provisions—But Not The THC Ban Delay Stakeholders Wanted appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Trump administration is issuing a reminder to U.S. Department of Transportation (DOT) substance abuse professionals (SAPs) about federal drug testing policies—including a directive to disregard attempts to justify positive tests for THC due to a worker’s use of medical marijuana or hemp oil. In a notice published in the Federal Register on Wednesday, DOT said SAPs have a “crucial role to play in recommending the level of treatment an employee may need in their path to returning to performing a safety-sensitive function after violating the DOT’s drug and alcohol testing regulations.” “SAPs represent the major decision point (and in some cases, the only decision point) an employer may have in choosing whether or not to place an employee behind the steering wheel of a school bus, in the cockpit of a plane, at the helm of an oil tanker, at the throttle of a train, in the engineer compartment of a subway car, or at the emergency control valves of a natural gas pipeline,” the notice says. “The SAP’s responsibility to the public is enormous.” The department said the reminder was deemed necessary after it “became aware” of “issues related to the SAP’s roles and responsibilities,” including with respect to when federally regulated transportation workers such as truck drivers may return to duty following a positive drug test. While it’s unclear whether any of those cases involved cannabis-related testing violations, DOT felt the need to specifically reiterate that, when making recommendations related to such violations, SAPs “must not take into consideration” any employee’s attempt to “mitigate the seriousness” of the situation by claiming they used marijuana for medical purposes as a majority of states authorize or hemp oil that’s federally legal but sometimes contains excess concentrations of THC that trigger positive test results. “Contact positives” are also not to be regarded as legitimate defenses against positive drug test results, nor should SAPs let a person’s consumption of food with poppyseeds factor into their recommendations for opioid-related violations, DOT said in the new notice. This doesn’t represent a new policy that’s been instituted by the Trump administration; rather, it simply echoes existing procedure under the Code of Federal Regulations (CFR). DOT Rule 49 CFR Part 40 Section 40.293 (Subpart O) states the following: “For purposes of your role in the evaluation process, you must assume that a verified positive test result has conclusively established that the employee committed a DOT drug and alcohol regulation violation. You must not take into consideration in any way, as a factor in determining what your recommendation will be, any of the following: A claim by the employee that the test was unjustified or inaccurate; Statements by the employee that attempt to mitigate the seriousness of a violation of a DOT drug or alcohol regulation (e.g., related to assertions of use of hemp oil, “medical marijuana” use, “contact positives,” poppy seed ingestion, job stress); or Personal opinions you may have about the justification or rationale for drug and alcohol testing.” Meanwhile, last year, DOT proposed a new rule to update its drug testing guidelines, revising terminology around cannabis in a way that provides more specificity related to THC. In a notice published in the Federal Register last September, DOT said it was proposing the rule change to “harmonize” with cannabis terminology adopted by the U.S. Department of Health and Human Services (HHS). — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In 2023, the department separately finalized a rule permitting another alternative option to screening urine samples: saliva-based testing. Depending on frequency of use, THC is generally detectable in saliva anywhere from one to 24 hours after use, according to the agency. A 2023 congressional report for a Transportation, Housing and Urban Development, and Related Agencies (THUD) bill, meanwhile, said that the House Appropriations Committee “continues to support the development of an objective standard to measure marijuana impairment and a related field sobriety test to ensure highway safety.” A year earlier Sen. John Hickenlooper (D-CO) sent a letter to DOT under the Biden administration seeking an update on that status of the federal report into research barriers that are inhibiting the development of that standardized test for marijuana impairment on the roads. The post Use Of Medical Marijuana Or Hemp Doesn’t Excuse Drug Testing Violations, Trump’s Transportation Department Warns appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Hey what a brilliant post I have come across and believe me I have been searching out for this similar kind of post for past a week and hardly came across this. Thank you very much and will look for more postings from you. UFABET ยูฟ่า เว็บพนันยอดนิยม

It's a superior strategies notably to help you the a newcomer to blogosphere, summary and even legitimate information… Bless you designed for writing this town. Required browse guide. 런닝레빗가라오케

VA marijuana sales & resentencing votes; FL legalization poll & court battle; WA & VA medical cannabis in hospitals; HI psychedelics; MI revenue Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Texas voters who participated in the Democratic primary election approved a marijuana ballot question that asks whether the state should “legalize cannabis for adults and automatically expunge criminal records for past low-level cannabis offenses”—by a margin of 80 percent to 20 percent. A new poll of Florida likely voters shows that 66 percent support legalizing marijuana, a result that comes as state officials are asking the Supreme Court to uphold their rejection of tens of thousands of signatures on cannabis ballot petitions. The Florida House of Representatives passed a bill to slash medical cannabis registration fees for military veterans—with the sponsor saying that marijuana helps with “managing chronic pain, alleviating the effects of PTSD, improving sleep and reducing the dependency on opioids.” The Virginia House of Delegates and Senate gave final passage to amended versions of each other’s bills to legalize recreational marijuana sales, and the House approved legislation to provide resentencing relief for prior cannabis convictions. The Virginia Senate and House of Delegates passed a bill to allow medical cannabis use in hospitals and create a new state working group to issue guidelines on the issue, teeing it up to be sent to Gov. Abigail Spanberger (D) after a technical error in companion legislation is fixed. Washington State lawmakers sent Gov. Bob Ferguson (D) a bill to allow terminally ill patients to use medical cannabis in healthcare facilities such as hospitals, nursing homes and hospices. The Hawaii Senate Ways and Means Committee approved a bill to create a psychedelics task force responsible for studying and making policy recommendations on providing access to breakthrough therapies such as psilocybin and MDMA. The Michigan Cannabis Regulatory Agency announced that the state is distributing nearly $94 million in marijuana tax revenue to 313 municipal, county and tribal governments to support various local infrastructure, education and other programs and services. / FEDERAL The U.S. Embassy and Consulates in Mexico sent a warning to U.S. citizens traveling for spring break that “drug possession and use, including of medical marijuana, is illegal in Mexico and may result in a lengthy jail sentence.” Former Rep. Matt Gaetz (R-FL) said positive results in a trial of 5-MeO-DMT benzoate are “great to see. Expanding access to psychedelics was the one legislative collaboration I had with @AOC.” / STATES California Gov. Gavin Newsom (D) touted efforts to combat sales of illegal kratom products. Oklahoma’s attorney general said the bond set by a court for the alleged leader of an illegal marijuana operation is too low. Kansas’s House speaker said his chamber will not take up marijuana reform unless the Senate acts first. A Pennsylvania representative is planning to file a bill to regulate hemp THC beverages. A Maryland senator discussed his bill to protect firefighters and rescue workers from being fired for off-duty medical cannabis use. A Michigan senator said the state attorney general could initiate an investigation into Menominee’s marijuana business approval process. A Virginia delegate said he is proud to have voted for a bill to legalize recreational marijuana sales even as a prohibitionist organization is targeting him in an ad. Washington, D.C. officials closed a medical cannabis cultivation facility over alleged violations. Minnesota regulators published a report on tax-delinquent cannabis businesses. The Tennessee Medical Cannabis Commission will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Los Angeles, California City Council voted to develop an amnesty program for tax-delinquent marijuana businesses. / INTERNATIONAL Canadian officials reported that the cannabis industry contributed nearly $11.6 billion to the country’s gross domestic product in 2025. / SCIENCE & HEALTH A study found that “contrary to the prevailing assumption that cannabis use exacerbates cognitive decline, our findings indicate an unexpected association between cannabis use and preserved cognitive functioning in psychosis.” A study found that “psilocybin sessions delivered under the Oregon regulatory model were associated with clinically meaningful improvements in depression, anxiety, and well-being 30-days post-session.” / BUSINESS RYTHM, Inc. reported quarterly revenue of $10.7 million and a net loss of $13.6 million. Trulieve Cannabis Corp. is laying off 58 employees at a customer service center in Clearwater, Florida. High Tide Inc. has new board of directors members. / CULTURE Wrestler Rob Van Dam said he would consider returning to the WWE now that it no longer drug tests for marijuana. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Max Jackson. The post Texas voters approve cannabis legalization ballot measure (Newsletter: March 5, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

We believe that great companionship should be accessible everywhere! That's why our agency has expanded to provide exceptional Escort In Delhi Area options across the entire region. Whether you are in a busy commercial hub or a serene suburb, a friendly and sophisticated companion is ready to make your acquaintance today. Escort Service in Indirapuram ITO Escort Escort in Janakpuri Jangpura Escort Service Escort Service Jhandewalan

Nice to read your article! I am looking forward to sharing your adventures and experiences. ทางเข้า ufabet123 ล่าสุด